CVS Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat
November 7, 2019 6:55 AM ESTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $71.00 price target on CVS Health (NYSE: CVS) following the company's 3Q earnings report. CVS reported 3Q:19 EPS of $1.84, above consensus of $1.76. Adjusted operating profit was $3.947bn versus consensus at $3.89bn.
The tone of... More
CVS Health (CVS) Trades to High, Up 5% Following Results Earllier
November 6, 2019 10:01 AM ESTCVS Health (NYSE: CVS) Trades to High, Up 5% Following Results Earllier
... MoreCVS Health (CVS) Tops Q3 EPS by 7c, Raises FY EPS Guidance
November 6, 2019 6:32 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.84, $0.07 better than the analyst estimate of $1.77. Revenue for the quarter came in at $64.8 billion versus the consensus estimate of $63.01 billion.
GUIDANCE:
CVS Health sees FY2019 EPS of $6.97-$7.05, versus the consensus of... More
